The VEGF165b "iCE-o-form" puts a chill on the VEGF story

Ayotunde O. Dokun, Brian H. Annex

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)246-247
Number of pages2
JournalCirculation research
Volume109
Issue number3
DOIs
StatePublished - Jul 22 2011
Externally publishedYes

Keywords

  • antiangiogenesis agents
  • ngiogenesis
  • vascular endothelial growth factor A

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

The VEGF165b "iCE-o-form" puts a chill on the VEGF story. / Dokun, Ayotunde O.; Annex, Brian H.

In: Circulation research, Vol. 109, No. 3, 22.07.2011, p. 246-247.

Research output: Contribution to journalEditorial

Dokun, Ayotunde O. ; Annex, Brian H. / The VEGF165b "iCE-o-form" puts a chill on the VEGF story. In: Circulation research. 2011 ; Vol. 109, No. 3. pp. 246-247.
@article{c9f81c864dfa40c2b037284a9f7ad94c,
title = "The VEGF165b {"}iCE-o-form{"} puts a chill on the VEGF story",
keywords = "antiangiogenesis agents, ngiogenesis, vascular endothelial growth factor A",
author = "Dokun, {Ayotunde O.} and Annex, {Brian H.}",
year = "2011",
month = "7",
day = "22",
doi = "10.1161/CIRCRESAHA.111.249953",
language = "English (US)",
volume = "109",
pages = "246--247",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The VEGF165b "iCE-o-form" puts a chill on the VEGF story

AU - Dokun, Ayotunde O.

AU - Annex, Brian H.

PY - 2011/7/22

Y1 - 2011/7/22

KW - antiangiogenesis agents

KW - ngiogenesis

KW - vascular endothelial growth factor A

UR - http://www.scopus.com/inward/record.url?scp=79961080792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961080792&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.111.249953

DO - 10.1161/CIRCRESAHA.111.249953

M3 - Editorial

C2 - 21778432

AN - SCOPUS:79961080792

VL - 109

SP - 246

EP - 247

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 3

ER -